Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;34(3):757-762.
doi: 10.1007/s12640-018-9913-3. Epub 2018 May 26.

Protective Effects of Donepezil Against Alcohol-Induced Toxicity in Cell Culture: Role of Caspase-3

Affiliations

Protective Effects of Donepezil Against Alcohol-Induced Toxicity in Cell Culture: Role of Caspase-3

Bruk Getachew et al. Neurotox Res. 2018 Oct.

Abstract

Ethanol (EtOH) is one of the most frequently abused drugs with heavy health, economic, and societal burdens. Although moderate to low EtOH may have some neuroprotective effects, heavy EtOH consumption associated with high blood alcohol level (BAL) can be quite detrimental. The brain is particularly vulnerable to the damaging effects of high BAL, leading to neuronal loss, cognitive, and behavioral deficits. Although the exact causes of these detriments are not fully elucidated, it is believed that damage to the cholinergic system is at least partially responsible for the cognitive impairment. Thus, high BAL may result in selective apoptotic damage to the cholinergic neurons. Donepezil (DON), a centrally acting, reversible and non-competitive acetylcholinesterase (AChE) inhibitor, approved for use in Alzheimer's disease (AD), may also attenuate EtOH-induced cognitive impairment. Cognitive effects of DON might be due to an anti-apoptotic activity as some AChE inhibitors have been shown to have this property. The aim of this study was to determine whether DON might protect against EtOH-induced toxicity and whether such protection might be apoptotically mediated. We exposed the human neuroblastoma-derived, SH-SY5Y cells to a relatively high concentration of EtOH (500 mM) for 24 h and evaluated the effects of two concentrations of DON (0.1 and 1.0 μM) on alcohol-induced toxicity and caspase-3, an apoptotic marker. We found a dose-dependent protection of DON against EtOH-induced toxicity as well as dose-dependent attenuation of EtOH-induced increases in caspase-3 levels. Thus, DON may inhibit apoptosis as well as alcohol-induced toxicity.

Keywords: Acetylcholinesterase inhibitor; Apoptosis; Caspase-3; Neuroprotection; Neurotoxicity; SH-SY5Y cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of different concentrations of ethanol (EtOH) on cell viability as determined by MTT assay in SH-SY5Y cells. Cells were incubated for 24 h. Values are mean ± SEM of 3 independent experiments. In every experiment, each sample was run in replicates of 6. *P<0.05, **P<0.01 compared to control.
Figure 2
Figure 2
Effects of donepezil (DON), 0.1 and 1 μM on EtOH-induced cell death in SH-SY5Y cells. DON was applied 2 h before EtOH (500 mM) and cells were incubated for 24 h. Values are mean ± SEM of 5 independent experiments. In every experiment, each sample was run in triplicate. **P<0.01 compared to control, ##P<0.01 compared to EtOH.
Figure 3
Figure 3
Effects of ethanol (EtOH) 500 mM and donepezil (DON 0.1 and 1 μM) alone or in combination on caspase-3 levels in SH-SY5Y cells. DON was applied 2 h before EtOH and cells were incubated for 24 h. Immunnoblots of beta-actin and total caspase-3 are included. Caspase-3 values were normalized per beta-actin protein. Values are mean ± SEM of 4 independent experiments. In every experiment, each sample was run in duplicate. **P<0.01 compared to control, #P<0.05, ##P<0.01 compared to EtOH.

References

    1. Akaike A, Takada-Takatori Y, Kume T, Izumi Y. Mechanisms of Neuroprotective Effects of Nicotine and Acetylcholinesterase Inhibitors: Role of α4 and α7 Receptors in Neuroprotection. J Mol Neurosci. 2010;40:211. - PubMed
    1. Antonelli M, Ferrulli A, Sestito L, Vassallo GA, Tarli C, Mosoni C. Alcohol addiction - the safety of available approved treatment options. Expert Opin Drug Saf. 2018;17:169–177. - PubMed
    1. Arendt T, Allen Y, Sinden J, Schugens MM, Marchbanks RM, et al. Cholinergic-rich brain transplants reverse alcohol-induced memory deficits. Nature. 1988;332:448–450. - PubMed
    1. Brats RT. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol. 2000;163:495–529. - PubMed
    1. Brodaty H. Realistic expectations for the management of Alzheimer’s disease. Eur Neuropsychopharmacol. 1999;9(Suppl 2):S43–S52. - PubMed

LinkOut - more resources